載入...
501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to bamlanivimab in vitro
The newly emerging variants of SARS-CoV-2 from South Africa (B.1.351/501Y.V2) and Brazil (P.1/501Y.V3) have led to a higher infection rate and reinfection of COVID-19 patients. We found that the mutations K417N, E484K, and N501Y within the receptor-binding domains (RBDs) of the virus could confer ~2...
Na minha lista:
Main Authors: | , , , , , , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
Taylor & Francis Group
2021-01-01
|
叢編: | mAbs |
主題: | |
在線閱讀: | https://www.tandfonline.com/doi/10.1080/19420862.2021.1919285 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|